Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Laying Out the Landscape in Today’s Patient Monitoring

Healthcare systems face fragmented monitoring approaches despite growing demand for real-time clinical insights across hospital units

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Intel on MarketScale.

Share

More and more hospital environments rely on continuous, high-quality data to support faster clinical decisions, but much of today's patient monitoring still varies widely by unit, device, and workflow. This episode kicks off a five-part Health and Life Sciences at the Edge series exploring The Future of Patient Monitoring. Intel's Kaeli Tully, Solutions Engineer for Healthcare and Life Sciences, and Dr. Sanjay Subramanian, Critical Care Physician and CEO/Founder of Omnicure, speak with Michelle Dawn Mooney about what patient monitoring looks like on the front lines and what it will take to spot decline earlier across the hospital.

Dr. Subramanian frames monitoring as a continuum across care intensity, noting that "hospitals are sort of and have always existed in two segments… the low-intensity segment and the high-intensity, which is the intensive care units." While most patients receive some level of vital signs monitoring, he explains that "the frequency with which that happens is highly variable," even though deterioration can occur without warning. In his view, "all patients deserve probably continuous monitoring," but the barrier is often cost and operational feasibility.

All patients deserve probably continuous monitoring.
— Dr. Sanjay Subramanian, Critical Care Physician and CEO/Founder of Omnicure

The conversation also highlights why monitoring matters most outside the ICU, especially when hospitals face crowding and staffing gaps. Dr. Subramanian emphasizes that critical care is strained by workforce realities, sharing that "most, I would say 80% of ICUs in the country, don't have dedicated 24-7 staffing by board-certified intensive care physicians," which accelerates interest in telecritical care and tele-ICU models. He describes how "ICU without walls" expands critical care beyond a fixed unit, recognizing that patients "deteriorate on the floors… in the emergency rooms, the operating theaters, and the PACUs." The goal becomes extending expertise and visibility wherever patients are.

From an infrastructure perspective, the episode digs into the challenge of heterogeneous device ecosystems and inconsistent access to data streams. Dr. Subramanian notes that "it becomes easier if the technology stack is homogenous," but many hospitals have "multiple devices of different ages" and cannot "reliably access the data from them." Looking forward, he identifies a clear priority: "We need to solve for getting access to data reliably, continuously, and that's high fidelity at scale," and pair it with "the appropriate workflows to make that data actionable."

We need to solve for getting access to data reliably, continuously, and that's high fidelity at scale.
— Dr. Sanjay Subramanian, Critical Care Physician and CEO/Founder of Omnicure

Learn more about patient monitoring innovation by connecting with Kaeli Tully and Dr. Sanjay Subramanian on LinkedIn, or by visiting Omnicure and Intel Health and Life Sciences.

Subscribe to this channel on Apple Podcasts and Spotify , and Google Podcasts to hear more from the Intel Network and Edge Solutions Group.

Intel

Part of this channel

Intel

Silicon and AI platforms powering enterprise and edge compute.

Visit the channel

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA-authorized digital medical devices have grown substantially over two decades, but regulatory databases still can't track them

FDA-authorized digital medical devices have grown substantially over two decades, but regulatory databases still can't track them

A Nature study reveals a significant increase in FDA-authorized digital medical devices over the past two decades. However, the FDA's regulatory databases are still unable to specify which of these devices contain software. This gap points to the need for improved database capabilities to better track digital medical devices.

  • 01FDA-authorized digital medical devices have increased significantly over the last 20 years.
  • 02The current FDA regulatory databases lack the capability to identify devices that include software.

Aug 5, 2026

Leading with Purpose: Dr. David Foster on Faith, Healthcare Leadership, and Physician Collaboration

Dr. David Foster discusses the importance of faith in healthcare leadership and the role of physician collaboration. The conversation emphasizes how values-driven leadership can positively impact patient care. The dialogue also explores the significance of integrating personal beliefs in professional settings.

  • 01Values-driven leadership can significantly enhance patient care.
  • 02Integrating personal beliefs in professional settings can benefit healthcare leadership.
  • 03Collaboration among physicians is crucial for effective healthcare leadership.

Aug 4, 2026

Digital health VC hits $7.4B in H1 2026 as AI agents, chronic care, and workforce tools capture mega-deal capital

Digital health VC hits $7.4B in H1 2026 as AI agents, chronic care, and workforce tools capture mega-deal capital

Digital health venture funding reached $7.4B in the first half of 2026, with significant investments in AI agent platforms and chronic care tools. Mega-deals of over $100 million were a key driver of the funding surge.

  • 01Digital health VC funding hit $7.4 billion in the first half of 2026.
  • 02Mega-deals in AI agent platforms and chronic care tools exceeded $100 million.
  • 03AI, chronic care, and workforce tools dominate digital health investments.

Aug 4, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512